非学术项目中，新辅助化疗或辅助化疗治疗可切除转移性结直肠癌的总生存。
In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program.
机构信息
Division of Medical Oncology, Biostatistics and Bioinformatics Shared Resource Facility, Markey Cancer Center, College of Medicine, University of Kentucky, Lexington, KY, USA.
出版信息
Oncologist. 2023 Jul 5;28(7):e590. doi: 10.1093/oncolo/oyad133.
Abstract
This letter to the editor responds to the letter from Su et al, regarding concerns related to immortal time bias that may partially account for recently published study results.
摘要
这封给编辑的信是对 Su 等人的来信的回应，信中提到了对不朽时间偏倚的担忧，这种偏倚可能部分解释了最近发表的研究结果。
相似文献
1
In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program.非学术项目中，新辅助化疗或辅助化疗治疗可切除转移性结直肠癌的总生存。
Oncologist. 2023 Jul 5;28(7):e590. doi: 10.1093/oncolo/oyad133.
2
Regarding "Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs".关于“非学术和学术项目中可切除转移性结直肠癌的新辅助化疗与辅助化疗”。
Oncologist. 2023 Jul 5;28(7):e588-e589. doi: 10.1093/oncolo/oyad130.
3
Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs.非学术和学术项目中可切除转移性结直肠癌的新辅助化疗与辅助化疗。
Oncologist. 2023 Jan 18;28(1):48-58. doi: 10.1093/oncolo/oyac209.
4
[Adjuvant and perioperative neoadjuvant therapy for colorectal cancer].[结直肠癌的辅助治疗和围手术期新辅助治疗]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Apr 25;22(4):315-320. doi: 10.3760/cma.j.issn.1671-0274.2019.04.002.
5
Neoadjuvant chemotherapy for locally advanced colonic cancer is the standard of care.局部晚期结肠癌的新辅助化疗是治疗的标准方法。
Br J Surg. 2023 Nov 9;110(12):1679-1680. doi: 10.1093/bjs/znad185.
6
7
Randomized Clinical Trials in Colon and Rectal Cancer.结直肠癌的随机临床试验
Surg Oncol Clin N Am. 2017 Oct;26(4):689-704. doi: 10.1016/j.soc.2017.05.008. Epub 2017 Aug 18.
8
Neoadjuvant chemotherapy for resectable colon cancer in the era of precision oncology: a step forward or a step back?精准肿瘤学时代可切除结肠癌的新辅助化疗：是前进还是后退？
Curr Opin Oncol. 2023 Jul 1;35(4):315-317. doi: 10.1097/CCO.0000000000000945.
9
Colorectal cancer: adjuvant chemotherapy for rectal cancer-an unresolved issue.结直肠癌：直肠癌的辅助化疗——一个尚未解决的问题。
Nat Rev Clin Oncol. 2014 Apr;11(4):182-4. doi: 10.1038/nrclinonc.2014.43. Epub 2014 Mar 18.
10
[Disputes and exploration of neoadjuvant and adjuvant therapy for colon cancer].[结肠癌新辅助和辅助治疗的争议与探索]
Zhonghua Wei Chang Wai Ke Za Zhi. 2019 Apr 25;22(4):329-335. doi: 10.3760/cma.j.issn.1671-0274.2019.04.004.
本文引用的文献
1
Regarding "Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs".关于“非学术和学术项目中可切除转移性结直肠癌的新辅助化疗与辅助化疗”。
Oncologist. 2023 Jul 5;28(7):e588-e589. doi: 10.1093/oncolo/oyad130.
2
Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs.非学术和学术项目中可切除转移性结直肠癌的新辅助化疗与辅助化疗。
Oncologist. 2023 Jan 18;28(1):48-58. doi: 10.1093/oncolo/oyac209.
Zotero 插件